mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for PUS10
Gene summary
Basic gene Info.Gene symbolPUS10
Gene namepseudouridylate synthase 10
SynonymsCCDC139|DOBI
CytomapUCSC genome browser: 2p16.1
Type of geneprotein-coding
RefGenesNM_144709.2,
Descriptioncoiled-coil domain containing 139coiled-coil domain-containing protein 139pseudouridine synthase 10psi55 synthaseputative tRNA pseudouridine synthase Pus10tRNA pseudouridine 55 synthasetRNA pseudouridylate synthasetRNA-uridine isomerase
Modification date20141207
dbXrefs MIM : 612787
HGNC : HGNC
Ensembl : ENSG00000162927
HPRD : 08126
Vega : OTTHUMG00000129423
ProteinUniProt: Q3MIT2
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_PUS10
BioGPS: 150962
PathwayNCI Pathway Interaction Database: PUS10
KEGG: PUS10
REACTOME: PUS10
Pathway Commons: PUS10
ContextiHOP: PUS10
ligand binding site mutation search in PubMed: PUS10
UCL Cancer Institute: PUS10
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for PUS10
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
C21P22SSKCM1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for PUS10
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
C21P22S-1.5093048
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for PUS10 from PDB

Top
Differential gene expression and gene-gene network for PUS10
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of PUS10 and the right PPI network was created from samples without mutations in the LBS of PUS10. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for PUS10
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for PUS10
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of PUS10 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
ZNZINC(2+)2v9kAC21


Top
Conservation information for LBS of PUS10
Multiple alignments for Q3MIT2 in multiple species
LBSAA sequence# speciesSpecies
C109SNLNVCNVCLG1Homo sapiens
C109ARLGVCSTCLG1Drosophila melanogaster
C109SKLRVCNVCLG1Mus musculus
C112NVCNVCLGILQ1Homo sapiens
C112GVCSTCLGLFS1Drosophila melanogaster
C112RVCNVCLGILQ1Mus musculus
C21LNTGTCPRCIF1Homo sapiens
C21RSCGVCEICQL1Drosophila melanogaster
C21FSSGTCPRCIL1Mus musculus
C24GTCPRCIFRFC1Homo sapiens
C24GVCEICQLRYL1Drosophila melanogaster
C24GTCPRCILRFC1Mus musculus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas